These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 18642854)
1. Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium. Patti GJ; Kim SJ; Schaefer J Biochemistry; 2008 Aug; 47(32):8378-85. PubMed ID: 18642854 [TBL] [Abstract][Full Text] [Related]
2. Characterization of structural variations in the peptidoglycan of vancomycin-susceptible Enterococcus faecium: understanding glycopeptide-antibiotic binding sites using mass spectrometry. Patti GJ; Chen J; Schaefer J; Gross ML J Am Soc Mass Spectrom; 2008 Oct; 19(10):1467-75. PubMed ID: 18692403 [TBL] [Abstract][Full Text] [Related]
3. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and Gargvanshi S; Vemula H; Gutheil WG J Bacteriol; 2021 Jul; 203(16):e0023021. PubMed ID: 34060906 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin and oritavancin have different modes of action in Enterococcus faecium. Patti GJ; Kim SJ; Yu TY; Dietrich E; Tanaka KS; Parr TR; Far AR; Schaefer J J Mol Biol; 2009 Oct; 392(5):1178-91. PubMed ID: 19576226 [TBL] [Abstract][Full Text] [Related]
5. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis. Chang JD; Foster EE; Yang H; Kim SJ Biochemistry; 2017 Jan; 56(4):612-622. PubMed ID: 28040891 [TBL] [Abstract][Full Text] [Related]
6. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance. Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112 [TBL] [Abstract][Full Text] [Related]
7. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner. van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282 [TBL] [Abstract][Full Text] [Related]
8. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type. Billot-Klein D; Shlaes D; Bryant D; Bell D; van Heijenoort J; Gutmann L Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):711-5. PubMed ID: 8611145 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence assay to predict activity of the glycopeptide antibiotics. Vimberg V; Gazak R; Szűcs Z; Borbás A; Herczegh P; Cavanagh JP; Zieglerova L; Závora J; Adámková V; Balikova Novotna G J Antibiot (Tokyo); 2019 Feb; 72(2):114-117. PubMed ID: 30504918 [TBL] [Abstract][Full Text] [Related]
10. Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium. Sacco E; Hugonnet JE; Josseaume N; Cremniter J; Dubost L; Marie A; Patin D; Blanot D; Rice LB; Mainardi JL; Arthur M Mol Microbiol; 2010 Feb; 75(4):874-85. PubMed ID: 20025663 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry. Chang JD; Foster EE; Thadani AN; Ramirez AJ; Kim SJ J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28507244 [TBL] [Abstract][Full Text] [Related]
12. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis. Singh M; Chang J; Coffman L; Kim SJ J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603 [TBL] [Abstract][Full Text] [Related]
13. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. Messer J; Reynolds PE FEMS Microbiol Lett; 1992 Jul; 73(1-2):195-200. PubMed ID: 1521770 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus. Kim SJ; Matsuoka S; Patti GJ; Schaefer J Biochemistry; 2008 Mar; 47(12):3822-31. PubMed ID: 18302341 [TBL] [Abstract][Full Text] [Related]
15. The Carboxyl Terminus of Eremomycin Facilitates Binding to the Non-d-Ala-d-Ala Segment of the Peptidoglycan Pentapeptide Stem. Chang J; Zhou H; Preobrazhenskaya M; Tao P; Kim SJ Biochemistry; 2016 Jun; 55(24):3383-91. PubMed ID: 27243469 [TBL] [Abstract][Full Text] [Related]
16. Desleucyl-Oritavancin with a Damaged d-Ala-d-Ala Binding Site Inhibits the Transpeptidation Step of Cell-Wall Biosynthesis in Whole Cells of Staphylococcus aureus. Kim SJ; Singh M; Sharif S; Schaefer J Biochemistry; 2017 Mar; 56(10):1529-1535. PubMed ID: 28221772 [TBL] [Abstract][Full Text] [Related]
17. Conformational and quantitative characterization of oritavancin-peptidoglycan complexes in whole cells of Staphylococcus aureus by in vivo 13C and 15N labeling. Cegelski L; Steuber D; Mehta AK; Kulp DW; Axelsen PH; Schaefer J J Mol Biol; 2006 Apr; 357(4):1253-62. PubMed ID: 16483598 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Arthur M; Depardieu F; Reynolds P; Courvalin P Mol Microbiol; 1996 Jul; 21(1):33-44. PubMed ID: 8843432 [TBL] [Abstract][Full Text] [Related]
19. Peptidoglycan composition of vancomycin-resistant Enterococcus faecium. de Jonge BL; Gage D; Handwerger S Microb Drug Resist; 1996; 2(2):225-9. PubMed ID: 9158764 [TBL] [Abstract][Full Text] [Related]
20. Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus. Kim SJ; Cegelski L; Stueber D; Singh M; Dietrich E; Tanaka KS; Parr TR; Far AR; Schaefer J J Mol Biol; 2008 Mar; 377(1):281-93. PubMed ID: 18258256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]